Survival rates By Mayo Clinic Staff The survival rates for ductal carcinoma in situ (DCIS) are excellent. DCIS is a noninvasive breast cancer. The cancer cells are contained within the milk ducts and haven't grown into nearby breast tissue. Most people diagnosed with DCIS are successfully treated, and the risk of dying from breast cancer is very low. Survival statisticsCancer survival rates come from studying many people with the same cancer to see how many are living years after diagnosis. The survival rate can give you an idea of survival for people in your situation. But the numbers can't predict your chances of survival. Studies of people with DCIS have found that the 10-year survival rate is greater than 98%. These statistics are based on people who had DCIS by itself, without an invasive breast cancer. DCIS is classified as stage 0 breast cancer when it occurs by itself. When DCIS occurs along with invasive breast cancer, the survival rate may vary by the stage of the invasive cancer rather than the DCIS. PrognosisCancer prognosis describes how likely it is that a cancer can be treated successfully or cured. It is based on the details of your cancer, as well as your overall health. If you want to understand your prognosis, talk with your healthcare team. Your team can explain the factors to consider and what they mean for you. The prognosis for DCIS is generally excellent. For most people, the cancer never comes back after treatment. Your risk of recurrence may depend on the specifics of your cancer. Factors that may affect prognosis include: Age at diagnosis. People diagnosed with DCIS before age 40 generally have a higher risk of recurrence than those diagnosed later in life. Cancer grade. Low-grade DCIS has a lower risk of recurrence than high-grade DCIS. How the DCIS was found. DCIS found through routine screening mammograms tends to have a lower risk of recurrence. If a breast lump or other symptoms lead to the diagnosis, there may be a higher risk of recurrence. Necrosis within the cancer. DCIS sometimes has areas of dead cells, called necrosis, among the cancer cells. When the necrosis forms in the middle of the DCIS, it's called comedo necrosis. Comedo necrosis raises the risk of recurrence. The size of the cancer. DCIS that affects a larger area of the breast may have a higher risk of recurrence than DCIS that involves a smaller area. Surgical margins. During a typical breast cancer surgery, the surgeon removes the cancer along with a small amount of the tissue that surrounds it. This tissue is called the margin. If the margin is free of cancer, the risk of recurrence is lower. Talk with your healthcare team about your risk of recurrence. Ask about treatments and other things you can do to lower the risk. Request an appointment StagesDoctors & departments Aug. 08, 2026 Share on: FacebookTwitter Living with ductal carcinoma in situ (DCIS)? Connect with others like you for support and answers to your questions in the Breast Cancer support group on Mayo Clinic Connect, a patient community. Breast Cancer Discussions Has anyone changed from Anastrozole to Exemestane? 27 Replies Fri, Aug 07, 2026 chevron-right Has anyone had a swollen lymph node under their armpit? 20 Replies Wed, Aug 05, 2026 chevron-right Triple Negative Breast Cancer: What treatments are you having? 259 Replies Mon, Aug 03, 2026 chevron-right See more discussions Show references Niederhuber JE, et al., eds. Cancer of the breast. In: Abeloff's Clinical Oncology. 6th ed. Elsevier; 2020. https://www.clinicalkey.com. Accessed March 1, 2024. Townsend CM Jr, et al. Diseases of the breast. In: Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 21st ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed March 1, 2024. Breast cancer. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1419. Accessed June 1, 2026. Abraham J, et al., eds. Breast cancer. In: The Bethesda Handbook of Clinical Oncology. 6th ed. Kindle edition. Wolters Kluwer; 2023. Accessed March 1, 2024. Collins LC, et al. Breast ductal carcinoma in situ: Epidemiology, clinical manifestations, and diagnosis. https://www.uptodate.com/contents/search. Accessed June 3, 2026. Distress management. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=3&id=1431. Accessed March 1, 2024. Record SM, et al. How to navigate the treatment spectrum from multimodality therapy to observation alone for ductal carcinoma in situ. Surgical Oncology Clinics of North America. 2023; doi:10.1016/j.soc.2023.05.011. Breast cancer prevention (PDQ) – Patient version. National Cancer Institute. https://www.cancer.gov/types/breast/patient/breast-prevention-pdq. Accessed March 1, 2024. In situ. Dorland's Medical Dictionary Online. https://www.dorlandsonline.com. Accessed June 5, 2026. Klimberg VS, et al., eds. Bland and Copeland's The Breast: Comprehensive Management of Benign and Malignant Diseases. 6th ed. Elsevier; 2024. https://www.clinicalkey.com. Accessed June 3, 2026. Collins LC, et al. Ductal carcinoma in situ: Treatment and prognosis. https://www.uptodate.com/contents/search. Accessed June 1, 2026. Collins LC, et al. Microinvasive breast carcinoma. https://www.uptodate.com/contents/search. Accessed June 3, 2026. Bleiweiss IJ. Pathology of breast cancer. https://www.uptodate.com/contents/search. Accessed June 3, 2026. Dabbs DJ. Ductal carcinoma in situ. In: Breast Pathology. 3rd ed. Elsevier; 2024. https://www.clinicalkey.com. Accessed June 5, 2026. Protocol for the examination of biopsy specimens from patients with ductal carcinoma in situ (DCIS) of the breast. College of American Pathologists. https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates. Accessed June 4, 2026. Cribriform. Dorland's Medical Dictionary Online. https://www.dorlandsonline.com. Accessed June 5, 2026. Delaloge S, et al. Ductal carcinoma in situ of the breast: Finding the balance between overtreatment and undertreatment. The Lancet. 2024; doi:10.1016/S0140-6736(24)00425-2. Protocol for the examination of resection specimens from patients with ductal carcinoma in situ (DCIS) of the breast. College of American Pathologists. https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates. Accessed June 4, 2026. Tumor grade. National Cancer Institute. https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/tumor-grade. Accessed April 16, 2026. Worni M, et al. Trends in treatment patterns and outcomes for ductal carcinoma in situ. Journal of the National Cancer Institute. 2015; doi:10.1093/jnci/djv263. Breast SPOREs. National Cancer Institute. https://dctd.cancer.gov/research/spores/focus-area/breast. Accessed April 17, 2026. Member institutions. Alliance for Clinical Trials in Oncology. https://www.allianceforclinicaltrialsinoncology.org/main/public/standard.xhtml?path=%2FPublic%2FInstitutions. Accessed April 17, 2026. Andreas A, et al., eds. The breast. In: Grainger & Allison's Diagnostic Radiology: A Textbook of Medical Imaging. 7th ed. Elsevier; 2021. https://www.clinicalkey.com. Accessed July 1, 2026. AskMayoExpert. Nipple discharge. Mayo Clinic; 2024. Related Associated Procedures Breast biopsy Breast cancer supportive therapy and survivorship Breast cancer surgery Breast MRI Lumpectomy Mastectomy MRI Needle biopsy Nipple-sparing mastectomy Radiation therapy Radiation therapy for breast cancer Ultrasound Show more associated procedures Products & Services A Book: Beyond Breast Cancer A Book: Mayo Clinic Family Health Book Newsletter: Mayo Clinic Health Letter — Digital Edition Show more products and services from Mayo Clinic Ductal carcinoma in situ (DCIS)Symptoms&causesDiagnosis&treatmentStagesSurvivalratesDoctors&departmentsCare atMayoClinic CON-20371874 Diseases & Conditions Ductal carcinoma in situ (DCIS)